This may reflect an important role for genes such as DAXX, ATRX, CHEK2, BRCA2, and TP53 in the rare malignant transformation of insulinomas; these genes may also provide clues to genes and pathways that must be avoided in attempts at therapeutic expansion of human beta cells. This evidence concerns the gene TP53 and pancreatic insulinoma.